Announcements Trials
Browse Landscape

Phase

Phase NA 115Phase 3 11Phase 2 11Phase 4 9Phase 2/3 3Phase 1/2 3Phase EARLY_PHASE1 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Postoperative Analgesia 1Neoplasms 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Control Groups × Clear all
NCT07505472 2026-04-01

STARS-RC10

The First Hospital of Jilin University

Phase 2/3 Recruiting
212 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed
6,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT03060070 2017-07-05

Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block

Assiut University

Phase 2/3 Completed
90 enrolled

Postoperative Analgesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡